Seizert Capital Partners LLC Buys New Holdings in LivaNova PLC (NASDAQ:LIVN)

Key Points

• Seizert Capital Partners LLC acquired 99,184 shares of LivaNova PLC, valued at approximately $3.9 million, representing a 0.18% ownership stake.
• Multiple institutional investors have significantly increased their positions in LivaNova, with UMB Bank n.a. raising their stake by 340.5% during the first quarter.
• LivaNova's stock performance includes a 1-year low of $32.48 and a high of $57.35, and it currently holds an average price target of $59.29 from analysts.

Seizert Capital Partners LLC acquired a new position in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 99,184 shares of the company's stock, valued at approximately $3,896,000. Seizert Capital Partners LLC owned about 0.18% of LivaNova as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also modified their holdings of the business. Russell Investments Group Ltd. lifted its stake in LivaNova by 17.1% during the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company's stock worth $70,000 after acquiring an additional 219 shares in the last quarter. Summit Investment Advisors Inc. increased its holdings in shares of LivaNova by 1.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 16,846 shares of the company's stock valued at $780,000 after acquiring an additional 289 shares during the last quarter. Central Pacific Bank Trust Division increased its holdings in shares of LivaNova by 7.0% in the 1st quarter. Central Pacific Bank Trust Division now owns 4,407 shares of the company's stock valued at $173,000 after acquiring an additional 290 shares during the last quarter. CWM LLC increased its holdings in shares of LivaNova by 52.3% in the 1st quarter. CWM LLC now owns 871 shares of the company's stock valued at $34,000 after acquiring an additional 299 shares during the last quarter. Finally, Mariner LLC grew its stake in LivaNova by 8.4% during the 4th quarter. Mariner LLC now owns 5,741 shares of the company's stock worth $266,000 after buying an additional 446 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on LIVN shares. Wolfe Research upgraded LivaNova from a "peer perform" rating to an "outperform" rating and set a $60.00 price target on the stock in a research note on Tuesday, May 20th. Barclays reduced their price target on LivaNova from $56.00 to $55.00 and set an "equal weight" rating for the company in a report on Thursday, May 8th. Robert W. Baird raised their price objective on LivaNova from $55.00 to $61.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Needham & Company LLC reaffirmed a "buy" rating and issued a $64.00 price objective on shares of LivaNova in a research note on Tuesday, May 13th. Finally, Wall Street Zen downgraded LivaNova from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 8th. One analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of $59.29.

LivaNova Trading Down 2.5%

Shares of NASDAQ:LIVN traded down $1.06 during midday trading on Friday, reaching $41.13. The company's stock had a trading volume of 800,401 shares, compared to its average volume of 602,376. The firm has a market cap of $2.24 billion, a price-to-earnings ratio of -10.06 and a beta of 0.92. The company has a quick ratio of 1.37, a current ratio of 1.58 and a debt-to-equity ratio of 0.53. LivaNova PLC has a 1 year low of $32.48 and a 1 year high of $57.35. The business has a 50 day moving average price of $44.65 and a 200 day moving average price of $42.94.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.